MA44680A - Compositions et procédés pour la production de composés - Google Patents
Compositions et procédés pour la production de composésInfo
- Publication number
- MA44680A MA44680A MA044680A MA44680A MA44680A MA 44680 A MA44680 A MA 44680A MA 044680 A MA044680 A MA 044680A MA 44680 A MA44680 A MA 44680A MA 44680 A MA44680 A MA 44680A
- Authority
- MA
- Morocco
- Prior art keywords
- compositions
- compounds
- processes
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/10—Nitrogen as only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/36—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Actinomyces; from Streptomyces (G)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662321439P | 2016-04-12 | 2016-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA44680A true MA44680A (fr) | 2019-02-20 |
Family
ID=60042244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA044680A MA44680A (fr) | 2016-04-12 | 2017-04-12 | Compositions et procédés pour la production de composés |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10907188B2 (fr) |
| EP (2) | EP4085933A3 (fr) |
| JP (1) | JP7187318B2 (fr) |
| KR (2) | KR102359972B1 (fr) |
| CN (1) | CN109641062A (fr) |
| AU (1) | AU2017249412B2 (fr) |
| CA (1) | CA3020594A1 (fr) |
| ES (1) | ES2921056T3 (fr) |
| MA (1) | MA44680A (fr) |
| WO (1) | WO2017180748A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9988624B2 (en) | 2015-12-07 | 2018-06-05 | Zymergen Inc. | Microbial strain improvement by a HTP genomic engineering platform |
| US11208649B2 (en) | 2015-12-07 | 2021-12-28 | Zymergen Inc. | HTP genomic engineering platform |
| WO2021163637A1 (fr) | 2020-02-13 | 2021-08-19 | Zymergen Inc. | Bibliothèque métagénomique et plateforme de découverte de produit naturel |
Family Cites Families (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0198026B1 (fr) | 1984-10-04 | 1993-08-04 | Sandoz Ag | Anticorps monoclonaux contre les cyclosporines |
| DE69013742T2 (de) | 1989-04-15 | 1995-03-23 | Nippon Chemiphar Co | Peptide und diese Peptide enthaltende Wirkstoffe gegen Dementia. |
| DE69302945T2 (de) | 1992-03-27 | 1996-10-10 | American Home Prod | 29-Demethoxyrapamycin zur Induktion der Immunosuppression |
| ATE297992T1 (de) | 1993-09-20 | 2005-07-15 | Univ Leland Stanford Junior | Recombinante herstellung aromatischer polyketiden |
| IL112873A (en) | 1994-03-08 | 2005-03-20 | Wyeth Corp | Rapamycin-fkbp12 binding proteins, their isolation and their use |
| GB9410142D0 (en) | 1994-05-20 | 1994-07-06 | Univ Warwick | Carbapenems |
| GB9524630D0 (en) | 1994-12-24 | 1996-01-31 | Zeneca Ltd | Chemical compounds |
| US6124453A (en) | 1995-07-04 | 2000-09-26 | Novartis Ag | Macrolides |
| JP2000511063A (ja) | 1996-07-05 | 2000-08-29 | バイオティカ テクノロジー リミティド | ポリケチド類及びそれらの合成 |
| SE9603465D0 (sv) | 1996-09-23 | 1996-09-23 | Astra Ab | New compounds |
| US6902913B2 (en) | 1997-04-30 | 2005-06-07 | Kosan Biosciences, Inc. | Recombinant narbonolide polyketide synthase |
| US6153383A (en) | 1997-12-09 | 2000-11-28 | Verdine; Gregory L. | Synthetic transcriptional modulators and uses thereof |
| EP1079859B1 (fr) | 1998-05-22 | 2010-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | Molecules bifonctionnelles et therapies basees sur celles-ci |
| DE69934242T2 (de) | 1998-10-02 | 2007-09-20 | Kosan Biosciences, Inc., Hayward | Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen |
| US6686454B1 (en) | 1998-10-09 | 2004-02-03 | Isotechnika, Inc. | Antibodies to specific regions of cyclosporine related compounds |
| WO2000047724A2 (fr) | 1999-02-09 | 2000-08-17 | Board Of Trustees Of The Leland Stanford Junior University | Procedes de modulation de l'efficacite de modules de polyketide-synthases |
| GB9927191D0 (en) | 1999-11-17 | 2000-01-12 | Angeletti P Ist Richerche Bio | Methods and means for regulation of gene expression |
| WO2001036612A1 (fr) | 1999-11-19 | 2001-05-25 | The Board Of Trustees Of The Leland Stanford Junior University | Molecules bifonctionnelles et leur utilisation pour inhiber des interactions proteine-proteine |
| WO2001059126A2 (fr) | 2000-02-08 | 2001-08-16 | Norges Teknisk Naturvitenskapelige Universitet | Nouveaux genes codant une polyketide de nystatine synthase, manipulation et utilisation |
| US7053057B2 (en) | 2000-05-23 | 2006-05-30 | Vertex Pharmaceuticals Incorporated | Caspase inhibitors and uses thereof |
| US7176037B2 (en) | 2000-07-13 | 2007-02-13 | The Scripps Research Institute | Labeled peptides, proteins and antibodies and processes and intermediates useful for their preparation |
| US20030153053A1 (en) | 2001-08-06 | 2003-08-14 | Ralph Reid | Methods for altering polyketide synthase genes |
| US6987090B2 (en) | 2002-05-09 | 2006-01-17 | Lg Household & Health Care Ltd. | Use of 3-position cyclosporin derivatives for hair growth |
| US7012065B2 (en) | 2003-02-07 | 2006-03-14 | Enanta Pharmaceuticals, Inc. | Cyclosporins for the treatment of immune disorders |
| EP1477563A3 (fr) | 2003-05-16 | 2004-11-24 | Wyeth | Clonage de gènes de Streptomyces cyaneogriseus subsp.noncyanogenus pour la biosynthèse des antibiotiques et procédés pour leur utilisation |
| JP2009528292A (ja) | 2006-02-27 | 2009-08-06 | ザ ボード オブ トラスティーズ オブ レランド スタンフォード ジュニア ユニバーシティ | 生物学的障壁を越える増強された放出特性を有する分子の輸送のための組成物および方法 |
| US20070203168A1 (en) | 2006-02-28 | 2007-08-30 | Zhao Jonathon Z | Isomers of rapamycin and 42-Epi-rapamycin, methods of making and using the same |
| KR100945483B1 (ko) * | 2007-10-25 | 2010-03-05 | 이화여자대학교 산학협력단 | ｐｉｋＤ 조절유전자의 발현벡터를 이용한 스트렙토미세스베네주엘라에（Ｓｔｒｅｐｔｏｍｙｃｅｓｖｅｎｅｚｕｅｌａｅ）에서폴리케타이드（ｐｏｌｙｋｅｔｉｄｅ）의 생산성 증가방법 |
| GB0805363D0 (en) | 2008-03-20 | 2008-04-30 | Sinvent As | Novel NRPS-PKS gene cluster and its manipulation and utility |
| EP2352526A1 (fr) | 2008-09-19 | 2011-08-10 | Protox Therapeutics Inc. | Traitement de cellules souches cancéreuses à l'aide de protéines cargo ciblées |
| ES2556211T3 (es) | 2008-09-24 | 2016-01-14 | Shanghai Institute Of Organic Chemistry, Chinese Academy Of Sciences | Agrupación de genes novedosa |
| BRPI1007476A2 (pt) | 2009-01-30 | 2016-02-16 | Enanta Pharm Inc | análogos de ciclosporina para prevenir ou tratar infecção por hepatite c |
| US9163330B2 (en) | 2009-07-13 | 2015-10-20 | President And Fellows Of Harvard College | Bifunctional stapled polypeptides and uses thereof |
| EP2456777A2 (fr) * | 2009-07-24 | 2012-05-30 | Université Henri Poincaré - Nancy 1 | Sambomycine et dérivés, leur production et leur utilisation en tant que médicaments |
| EP2480565A4 (fr) | 2009-09-22 | 2014-01-01 | Aileron Therapeutics Inc | Macrocycles peptidomimétiques |
| JP5174971B2 (ja) | 2009-10-22 | 2013-04-03 | ペプチドリーム株式会社 | ペプチド翻訳合成におけるｒａｐｉｄディスプレイ法 |
| KR101189475B1 (ko) * | 2009-12-03 | 2012-10-15 | (주) 제노텍 | 삼원환 화합물의 생합성을 담당하는 유전자와 단백질 |
| AU2011336727B2 (en) | 2010-11-30 | 2016-11-03 | The Johns Hopkins University | Hybrid cyclic libraries and screens thereof |
| US9428845B1 (en) | 2010-12-28 | 2016-08-30 | Warp Drive Bio, Inc. | Identifying new therapeutic agents |
| WO2012174489A2 (fr) | 2011-06-15 | 2012-12-20 | The Ohio State University | Surfaces composites à petites molécules en tant qu'inhibiteurs d'interactions protéine-protéine |
| DE102011111991A1 (de) | 2011-08-30 | 2013-02-28 | Lead Discovery Center Gmbh | Neue Cyclosporin-Derivate |
| EP3348280A1 (fr) | 2012-07-12 | 2018-07-18 | Hangzhou Dac Biotech Co., Ltd | Conjugués de molécules de liaison cellulaire à des agents cytotoxiques |
| CA2891280C (fr) | 2012-11-24 | 2018-03-20 | Hangzhou Dac Biotech Co., Ltd. | Lieurs hydrophiles et leurs utilisations pour la conjugaison de medicaments a des molecules se liant aux cellules |
| EP2806274A1 (fr) | 2013-05-24 | 2014-11-26 | AIT Austrian Institute of Technology GmbH | Procédé de diagnostic du cancer du colon et moyens associés |
| US10233431B2 (en) | 2014-02-26 | 2019-03-19 | The Regents Of The University Of California | Producing 3-hydroxycarboxylic acid and ketone using polyketide synthases |
| CN106255882A (zh) * | 2014-03-03 | 2016-12-21 | 耶路撒冷希伯来大学伊森姆研究发展公司 | 用于检测铜绿假单胞菌的方法和装置 |
| TW201629069A (zh) | 2015-01-09 | 2016-08-16 | 霍普驅動生物科技股份有限公司 | 參與協同結合之化合物及其用途 |
| WO2016112295A1 (fr) | 2015-01-09 | 2016-07-14 | Warp Drive Bio, Inc. | Composés participant à une liaison de coopérativité et leurs utilisations |
| US10077289B2 (en) | 2015-03-31 | 2018-09-18 | Allergan, Inc. | Cyclosporins modified on the MeBmt sidechain by heterocyclic rings |
| EP3355930A4 (fr) | 2015-10-01 | 2019-03-06 | Warp Drive Bio, Inc. | Procédés et réactifs pour l'analyse d'interfaces protéine-protéine |
| KR20190099396A (ko) | 2016-10-28 | 2019-08-27 | 징코 바이오웍스, 인크. | 화합물의 생산을 위한 조성물 및 방법 |
-
2017
- 2017-04-12 MA MA044680A patent/MA44680A/fr unknown
- 2017-04-12 WO PCT/US2017/027215 patent/WO2017180748A1/fr active Application Filing
- 2017-04-12 KR KR1020187032679A patent/KR102359972B1/ko active IP Right Grant
- 2017-04-12 KR KR1020227003633A patent/KR102615448B1/ko active IP Right Grant
- 2017-04-12 EP EP22162958.7A patent/EP4085933A3/fr active Pending
- 2017-04-12 EP EP17783058.5A patent/EP3442599B1/fr active Active
- 2017-04-12 US US16/093,074 patent/US10907188B2/en active Active
- 2017-04-12 CN CN201780030563.7A patent/CN109641062A/zh active Pending
- 2017-04-12 AU AU2017249412A patent/AU2017249412B2/en active Active
- 2017-04-12 JP JP2018553412A patent/JP7187318B2/ja active Active
- 2017-04-12 CA CA3020594A patent/CA3020594A1/fr active Pending
- 2017-04-12 ES ES17783058T patent/ES2921056T3/es active Active
-
2021
- 2021-01-29 US US17/163,016 patent/US11447810B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA3020594A1 (fr) | 2017-10-19 |
| AU2017249412B2 (en) | 2022-07-07 |
| AU2017249412A1 (en) | 2018-11-08 |
| KR102359972B1 (ko) | 2022-02-10 |
| US20190136284A1 (en) | 2019-05-09 |
| US11447810B2 (en) | 2022-09-20 |
| EP4085933A3 (fr) | 2023-01-11 |
| JP2019511231A (ja) | 2019-04-25 |
| EP4085933A2 (fr) | 2022-11-09 |
| EP3442599A1 (fr) | 2019-02-20 |
| KR20190005872A (ko) | 2019-01-16 |
| US20210238646A1 (en) | 2021-08-05 |
| WO2017180748A1 (fr) | 2017-10-19 |
| US10907188B2 (en) | 2021-02-02 |
| ES2921056T3 (es) | 2022-08-17 |
| EP3442599B1 (fr) | 2022-03-30 |
| EP3442599A4 (fr) | 2019-09-25 |
| CN109641062A (zh) | 2019-04-16 |
| KR102615448B1 (ko) | 2023-12-19 |
| KR20220021019A (ko) | 2022-02-21 |
| JP7187318B2 (ja) | 2022-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL258324B (en) | Methods to create various cannabis product compounds | |
| MA49858A (fr) | Composés, compositions et procédés | |
| MA47576A (fr) | Composés inhibiteurs d'oga bicyclique | |
| MA53246A (fr) | Composés et procédés pour favoriser la myélinisation | |
| MA51878A (fr) | Composés d'aminothiazole en tant qu'inhibiteurs de c-kit | |
| MA50063A (fr) | Composés, compositions et procédés | |
| MA46427A (fr) | Compositions d'oligonucléotides et procédés associés | |
| MA40587A (fr) | Composés d'aminopyrimidinyle en tant qu'inhibiteurs de jak | |
| MA41253A (fr) | Composés, compositions et procédés pour augmenter l'activité du cftr | |
| MA49752A (fr) | Procédés de préparation de composés de pyrrolidine | |
| GB2558335B (en) | Novel processes for the production of oligonucleotides | |
| MA42829A (fr) | Compositions dérivées de placenta et procédés pour les produire | |
| EP3532633A4 (fr) | Compositions et procédés pour la production de composés | |
| MA46878A (fr) | Composés de benzodiazolium en tant qu'inhibiteurs d'enac | |
| IT201600105178A1 (it) | Procedimento per la produzione di dieni | |
| MA41203A (fr) | Procédés pour la préparation d'un composé diaryl-thiohydantoïne | |
| DK3436547T3 (da) | Proces til fremstilling af råolieprodukter | |
| MA49610A (fr) | Procédés et compositions pour améliorer la production de myéline fonctionnelle | |
| MA50169A (fr) | Procédé de production d'un électrocatalyseur | |
| EP3532055A4 (fr) | Compositions et procédés pour la production de composés | |
| ZA201902125B (en) | Process for the production of 2-alkylalkanol | |
| MA42423A (fr) | Procédé de préparation d'un revêtement | |
| MA46431A (fr) | Composés et procédés pour réduire l'expression de tau | |
| MA44680A (fr) | Compositions et procédés pour la production de composés | |
| BR112016019246A2 (pt) | processo paraa fabricação de hidroclorofluoro-olefinas |